6 Heddon Street
London W1B 4BT
United Kingdom
https://genflowbio.com
Sector(s): Healthcare
Industry: Biotechnology
Full-time employees: 5
Name | Title | Pay | Exercised | Year born |
---|---|---|---|---|
Dr. Eric Jean Leire M.D., MBA | Founder, CEO & Executive Director | 232.01k | N/A | 1958 |
Dr. Cedric Szpirer | Head of CMC | N/A | N/A | N/A |
Genflow Biosciences plc, together with its subsidiaries, operates as a biotechnology company that focuses on developing biological interventions aimed at tackling the effects of ageing, slowing, and halting the ageing process, and reducing the incidence of age-related diseases with increase in health span in the United Kingdom and Belgium. Its lead compound is GF-1002, a suspension of an adeno-associated viral vector-based gene therapy for intravenous infusion. The company is also developing GF-3001, a topical delivery of SIRT6 to the skin; and GF-4001, a non-human pipeline anti-aging for veterinary use. Genflow Biosciences plc was incorporated in 2021 and is headquartered in London, the United Kingdom.
Genflow Biosciences plc’s ISS governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder rights: N/A; Compensation: N/A.